February 2, 2026: Brazilian Company May Offer Generic Semaglutide Drugs, Like Rybelsus Hypera, a drug company in Brazil, has announced plans to make a cheaper, generic version of semaglutide in March 2026, when Novo Nordisks patent protections expire in Brazil
As both an injectable and an oral pill, semaglutide functions by mimicking the natural hormone GLP-1, which helps reduce appetite and supports sustained weight loss
As discussed previously, we proposed that if the negotiated percentage or algorithm associated with the allowed amounts was only used for a portion of the 12-month time period prior to posting the file, the hospital would encode the median allowed amount, 10th and 90th percentile allowed amounts, and count of allowed amounts from the EDI 835 ERA transaction data for the portion of time that the percentage or algorithm was used
European Union Varies by country: Some countries very permissive (Eastern Europe) Others strict (Germany, France) EU-wide regulations exist but enforcement varies General pattern: Prescription peptides require prescription, research peptides gray area
